Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data

References

• Centers for Disease Control and Prevention. Data and trends, National Diabetes Surveillance System, 2005. Available from http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm [Last accessed 19 May 2006]
   Google Scholar
• Centers for Disease Control and Prevention. National diabetes fact sheet, 2003. Available from http://www.cdc.gov/diabetes/pubs/estimates05.htm#prev [Last accessed 19 May 2006]
   Google Scholar
• Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004;140: 945–50
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990–1998. Diabetes Care 2000;23:1278–83
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76–9
   PubMed Web of Science ®Google Scholar
• Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26: 917–32
   Google Scholar
• Ramsey S, Summers KH, Leong SA, et al. Productivity and medical costs of diabetes in a large employer population. Diabetes Care 2002;25:23–9
   PubMed Web of Science ®Google Scholar
• Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300–4
   PubMed Web of Science ®Google Scholar
• Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523–9
   PubMed Web of Science ®Google Scholar
• Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006;12:75–80
   PubMed Web of Science ®Google Scholar
• Daousi C, Casson IF, Gill GV, et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006;82:280–4
   PubMed Web of Science ®Google Scholar
• Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214–22
   Google Scholar
• Resnick HE, Valsania P, Halter JB, et al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000;54:596–602
   PubMed Web of Science ®Google Scholar
• Eckel RH, Kahn R, Robertson RM, et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care 2006;29:1697–9
   PubMed Web of Science ®Google Scholar
• Serrano Rios M. Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998;28:14–7
   PubMed Web of Science ®Google Scholar
• Zinman B. Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers. Diabetologia 1997;40:S88–90
   PubMed Web of Science ®Google Scholar
• Chan JL, Abrahamson MJ. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc 2003;78:459–67
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86
   Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837–53
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2007. Diabetes Care 2007;30:S4–41
   PubMedGoogle Scholar
• Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 2003;115:42S–8
   Google Scholar
• Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM 2000;93:369–74
   PubMed Web of Science ®Google Scholar
• Douek IF, Gale EAM. The problem of weight gain on insulin. In: Barnett AH, editor. Insulin made easy. London: Medical Education Partnership, 2001. pp.80–9
   Google Scholar
• United-Kingdom PDSG. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998;128:165–75
   PubMed Web of Science ®Google Scholar
• Lamotte M, Annemans L, Lefever A, et al. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Diabetes Care 2002;25:303–8
   PubMed Web of Science ®Google Scholar
• Markovic TP, Campbell LV, Balasubramanian S, et al. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Diabetes Care 1998;21:695–700
   PubMed Web of Science ®Google Scholar
• Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000;23:1499–504
   PubMed Web of Science ®Google Scholar
• Wolf AM, Conaway MR, Crowther JQ, et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. Diabetes Care 2004;27:1570–6
   PubMed Web of Science ®Google Scholar
• Fabricatore AN, Wadden TA. Treatment of obesity: an overview. Clinical Diabetes 2003;21:67–72
   Google Scholar
• Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004;110:2952–67
   PubMed Web of Science ®Google Scholar
• Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Asses 2004;8: iii-iv,1–182
   Google Scholar
• The U.S. Department of Health and Human Services. The international classification of diseases, 9th revision, clinical modification. 4th edn. Washington, DC, 1991
   Google Scholar
• Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115: 114–26
   PubMed Web of Science ®Google Scholar
• National Heart, Lung and Blood Institute. Aim for a healthy weight. Available from http://www.nhlbi.nih.gov [Last accessed 31 May 2006]
   Google Scholar
• World Health Organization Expert Committee on Physical Status. The use and interpretation of anthropometry. Report of a World Health Organization Expert Committee. Technical support, series 854, 1995. Geneva: World Health Organization
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613–9
   Google Scholar
• Klabunde CN. Does the outpatient experience matter? Incorporating outpatient care in a comorbidity index for use with large administrative claims datasets. Abstr Book Assoc Health Serv Res Meet 1997;14:330–9
   Google Scholar
• Ash AS, Posner MA, Speckman J, et al. Using claims data to examine mortality trends following hospitalization for heart attack in Medicare. Health Serv Res 2003;38:1253–62
   PubMed Web of Science ®Google Scholar
• Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs. Cox proportional hazard? Health Econ 2004;13:749–65
   Google Scholar
• Pi-Sunyer FX. Weight and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1996;63:426S–29
   Google Scholar
• Clarke P, Gray A, Adler A, et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51). Diabetologia 2001;44: 298–304
   Google Scholar
• Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518–23
   PubMed Web of Science ®Google Scholar
• Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323–32
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403
   PubMed Web of Science ®Google Scholar
• Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes – 2006: a position statement of the American Diabetes Association. Diabetes Care 2006;29:2140–57
   PubMed Web of Science ®Google Scholar
• Franz MJ, Bantle JP, Beebe CA, et al. Nutrition principles and recommendations in diabetes. Diabetes Care 2004;27: S36–46
   PubMedGoogle Scholar
• American Diabetes Association task force for writing nutrition principles and recommendations for the management of diabetes and related complications. American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. J Am Diet Assoc 2002;102: 109–18
   PubMed Web of Science ®Google Scholar
• Hu FB, Li TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003;289:1785–91
   PubMed Web of Science ®Google Scholar
• Gandjour A, Westenhofer J, Wirth A, et al. Development process of an evidence-based guideline for the treatment of obesity. Int J Qual Health Care 2001;13:325–32
   PubMed Web of Science ®Google Scholar
• Nawaz H, Katz DL. American College of Preventive Medicine practice policy statement. Weight management counseling of overweight adults. Am J Prev Med 2001;21:73–8
   PubMed Web of Science ®Google Scholar
• Foreyt JP, Poston WS 2nd. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. Int J Obes Relat Metab Disord 1999;23:S5–11
   PubMed Web of Science ®Google Scholar